NEW YORK, October 30, 2017 /PRNewswire/ --
If you want a Stock Review on IDXG, ITUS, MARA, or VRSK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. This morning, DailyStockTracker.com evaluates Interpace Diagnostics Group Inc. (NASDAQ: IDXG), ITUS Corp. (NASDAQ: ITUS), Marathon Patent Group Inc. (NASDAQ: MARA), and Verisk Analytics Inc. (NASDAQ: VRSK). Business Services companies provide support services to businesses, such as office administration, hiring and placing of personnel, security services, travel arrangement, cleaning, and waste disposal. Learn more about these stocks by signing up for their free reports on DailyStockTracker.com at:
http://dailystocktracker.com/register/
Interpace Diagnostics Group
Last Friday, Parsippany, New Jersey headquartered Interpace Diagnostics Group Inc.'s stock closed the day flat at $1.25. A total volume of 631,109 shares was traded. The Company's shares have advanced 37.60% in the previous three months. The stock is trading 14.00% below its 50-day moving average. Additionally, shares of Interpace Diagnostics, which develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers, have a Relative Strength Index (RSI) of 38.69.
On October 11th, 2017, Interpace Diagnostics Group (IDXG) announced that reimbursement for its ThyGenX® molecular test for indeterminate thyroid nodules will increase by 40% starting January 01st, 2018. Medicare has covered ThyGenX since 2015, and in January 2016, it initiated coverage of ThyraMIR®, IDXG's miRNA-based product. Overall, Medicare represents approximately 40% of IDXG's volume for the ThyGenX test; given the latter's recent announcements of coverage for ThyGenX among numerous commercial health plans, the overall payer mix for the remainder of the volume has improved significantly since 2016. The free research report on IDXG is available at:
http://dailystocktracker.com/registration/?symbol=IDXG
ITUS Corp.
Shares in Los Angeles, California-based ITUS Corp. rose 3.13%, finishing Friday's session at $1.98. The stock recorded a trading volume of 1.92 million shares. The Company's shares have surged 150.63% over the previous three months. The stock is trading above its 50-day moving average by 5.11%. Furthermore, shares of ITUS Corp., which develops, acquires, and licenses emerging technologies in the areas of biotechnology, have an RSI of 42.32.
On October 27th, 2017, ITUS Corp. announced that it has satisfied all obligations under its secured debenture by paying the creditor the outstanding principal and interest in cash ahead of its due date. As a result of this debt retirement, the Company currently has no significant debt obligations. The complimentary report on ITUS can be downloaded at:
http://dailystocktracker.com/registration/?symbol=ITUS
Marathon Patent Group
Los Angeles, California headquartered Marathon Patent Group Inc.'s stock finished 13.31% lower at $0.35 last Friday at the close. A total volume of 2.30 million shares was traded, which was higher than their three months average volume of 1.79 million shares. The Company's shares have advanced 13.23% in the previous three months. The stock is trading below its 50-day moving average by 8.63%. Additionally, shares of Marathon Patent, which together with its subsidiaries, acquires and monetizes patents primarily in the US, have an RSI of 41.84.
On October 25th, 2017, Marathon Patent announced that it has received written confirmation from NASDAQ that the Company has regained compliance with NASDAQ Listing Rule 5550(b)(1), which requires companies listed on The NASDAQ Capital Market to maintain stockholders' equity of at least US $2.5 million. Visit us today and download our complete research report on MARA for free at:
http://dailystocktracker.com/registration/?symbol=MARA
Verisk Analytics
Jersey City, New Jersey headquartered Verisk Analytics Inc.'s shares ended the session 0.13% higher at $84.94. The stock recorded a trading volume of 1.17 million shares, which was above its three months average volume of 709,870 shares. Shares of the Company have advanced 3.08% in the last month and 4.64% on an YTD basis. The stock is trading 3.07% above its 50-day moving average and 3.37% above its 200-day moving average. Moreover, shares of Verisk Analytics, which provides data analytics solutions for customers in the insurance, natural resources, healthcare, financial services, and risk management markets in the US and internationally, have an RSI of 65.78.
On October 26th, 2017, AIR Worldwide ("AIR"), a catastrophe modeling business of Verisk Analytics, announced that it estimates that industry-insured losses from the Tubbs, Pocket, Nuns, Atlas, Redwood, and Sulphur fires in California will be between USD $2 billion and USD $3 billion. AIR's loss estimates explicitly capture residential, mobile home, commercial, and automobile losses, as well as direct business interruption losses. Get free access to your technical report on VRSK at:
http://dailystocktracker.com/registration/?symbol=VRSK
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE dailystocktracker.com
Advertisement
If you want a Stock Review on IDXG, ITUS, MARA, or VRSK then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. This morning, DailyStockTracker.com evaluates Interpace Diagnostics Group Inc. (NASDAQ: IDXG), ITUS Corp. (NASDAQ: ITUS), Marathon Patent Group Inc. (NASDAQ: MARA), and Verisk Analytics Inc. (NASDAQ: VRSK). Business Services companies provide support services to businesses, such as office administration, hiring and placing of personnel, security services, travel arrangement, cleaning, and waste disposal. Learn more about these stocks by signing up for their free reports on DailyStockTracker.com at:
Advertisement
http://dailystocktracker.com/register/
Interpace Diagnostics Group
Last Friday, Parsippany, New Jersey headquartered Interpace Diagnostics Group Inc.'s stock closed the day flat at $1.25. A total volume of 631,109 shares was traded. The Company's shares have advanced 37.60% in the previous three months. The stock is trading 14.00% below its 50-day moving average. Additionally, shares of Interpace Diagnostics, which develops and commercializes molecular diagnostic tests to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers, have a Relative Strength Index (RSI) of 38.69.
On October 11th, 2017, Interpace Diagnostics Group (IDXG) announced that reimbursement for its ThyGenX® molecular test for indeterminate thyroid nodules will increase by 40% starting January 01st, 2018. Medicare has covered ThyGenX since 2015, and in January 2016, it initiated coverage of ThyraMIR®, IDXG's miRNA-based product. Overall, Medicare represents approximately 40% of IDXG's volume for the ThyGenX test; given the latter's recent announcements of coverage for ThyGenX among numerous commercial health plans, the overall payer mix for the remainder of the volume has improved significantly since 2016. The free research report on IDXG is available at:
http://dailystocktracker.com/registration/?symbol=IDXG
ITUS Corp.
Shares in Los Angeles, California-based ITUS Corp. rose 3.13%, finishing Friday's session at $1.98. The stock recorded a trading volume of 1.92 million shares. The Company's shares have surged 150.63% over the previous three months. The stock is trading above its 50-day moving average by 5.11%. Furthermore, shares of ITUS Corp., which develops, acquires, and licenses emerging technologies in the areas of biotechnology, have an RSI of 42.32.
On October 27th, 2017, ITUS Corp. announced that it has satisfied all obligations under its secured debenture by paying the creditor the outstanding principal and interest in cash ahead of its due date. As a result of this debt retirement, the Company currently has no significant debt obligations. The complimentary report on ITUS can be downloaded at:
http://dailystocktracker.com/registration/?symbol=ITUS
Marathon Patent Group
Los Angeles, California headquartered Marathon Patent Group Inc.'s stock finished 13.31% lower at $0.35 last Friday at the close. A total volume of 2.30 million shares was traded, which was higher than their three months average volume of 1.79 million shares. The Company's shares have advanced 13.23% in the previous three months. The stock is trading below its 50-day moving average by 8.63%. Additionally, shares of Marathon Patent, which together with its subsidiaries, acquires and monetizes patents primarily in the US, have an RSI of 41.84.
On October 25th, 2017, Marathon Patent announced that it has received written confirmation from NASDAQ that the Company has regained compliance with NASDAQ Listing Rule 5550(b)(1), which requires companies listed on The NASDAQ Capital Market to maintain stockholders' equity of at least US $2.5 million. Visit us today and download our complete research report on MARA for free at:
http://dailystocktracker.com/registration/?symbol=MARA
Verisk Analytics
Jersey City, New Jersey headquartered Verisk Analytics Inc.'s shares ended the session 0.13% higher at $84.94. The stock recorded a trading volume of 1.17 million shares, which was above its three months average volume of 709,870 shares. Shares of the Company have advanced 3.08% in the last month and 4.64% on an YTD basis. The stock is trading 3.07% above its 50-day moving average and 3.37% above its 200-day moving average. Moreover, shares of Verisk Analytics, which provides data analytics solutions for customers in the insurance, natural resources, healthcare, financial services, and risk management markets in the US and internationally, have an RSI of 65.78.
On October 26th, 2017, AIR Worldwide ("AIR"), a catastrophe modeling business of Verisk Analytics, announced that it estimates that industry-insured losses from the Tubbs, Pocket, Nuns, Atlas, Redwood, and Sulphur fires in California will be between USD $2 billion and USD $3 billion. AIR's loss estimates explicitly capture residential, mobile home, commercial, and automobile losses, as well as direct business interruption losses. Get free access to your technical report on VRSK at:
http://dailystocktracker.com/registration/?symbol=VRSK
--
Daily Stock Tracker:
Daily Stock Tracker (DST) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. DST has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
DST has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email [email protected] . Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by DST. DST is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
NO WARRANTY
DST, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. DST, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, DST, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither DST nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
http://dailystocktracker.com/disclaimer/
CONTACT For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at: Email: [email protected] Phone number: (207)331-3313 Office Address: 377 Rivonia Boulevard, Rivonia, South Africa
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE dailystocktracker.com
